405 related articles for article (PubMed ID: 32809231)
1. The cancer patient and cardiology.
Zamorano JL; Gottfridsson C; Asteggiano R; Atar D; Badimon L; Bax JJ; Cardinale D; Cardone A; Feijen EAM; Ferdinandy P; López-Fernández T; Gale CP; Maduro JH; Moslehi J; Omland T; Plana Gomez JC; Scott J; Suter TM; Minotti G
Eur J Heart Fail; 2020 Dec; 22(12):2290-2309. PubMed ID: 32809231
[TBL] [Abstract][Full Text] [Related]
2. An Overview of Cardio-Oncology, a New Frontier to Be Explored.
Cheng KH; Wu YW; Hou CJ; Hung CM
Acta Cardiol Sin; 2021 Sep; 37(5):457-463. PubMed ID: 34584378
[TBL] [Abstract][Full Text] [Related]
3. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
Zamorano JL; Lancellotti P; Rodriguez Muñoz D; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GYH; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM;
Eur Heart J; 2016 Sep; 37(36):2768-2801. PubMed ID: 27567406
[No Abstract] [Full Text] [Related]
4. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
[TBL] [Abstract][Full Text] [Related]
5. Strategies to Prevent Cardiotoxicity.
Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxicity of Contemporary Breast Cancer Treatments.
Lee Chuy K; Yu AF
Curr Treat Options Oncol; 2019 May; 20(6):51. PubMed ID: 31073788
[TBL] [Abstract][Full Text] [Related]
7. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
[TBL] [Abstract][Full Text] [Related]
8. Cardio-oncology: Gaps in Knowledge, Goals, Advances, and Educational Efforts.
Biasillo G; Cipolla CM; Cardinale D
Curr Oncol Rep; 2017 Aug; 19(8):55. PubMed ID: 28707189
[TBL] [Abstract][Full Text] [Related]
9. European Society of Cardiology Core Curriculum for cardio-oncology.
López-Fernández T; Farmakis D; Ameri P; Asteggiano R; de Azambuja E; Aznar M; Barac A; Bayes-Genis A; Bax JJ; Bergler-Klein J; Boriani G; Celutkiene J; Coats A; Cohen-Solal A; Córdoba R; Cosyns B; Filippatos G; Fox K; Gulati G; Inciardi RM; Lee G; Mamas MA; Novo G; Plummer C; Psyrri A; Rakisheva A; Suter T; Tini G; Tocchetti CG; Toutouzas K; Wilhelm M; Metra M; Lyon AR; Rosano GMC
Eur J Heart Fail; 2024 Apr; 26(4):754-771. PubMed ID: 38059343
[TBL] [Abstract][Full Text] [Related]
10. Management and research in cancer treatment-related cardiovascular toxicity: Challenges and perspectives.
Cautela J; Lalevée N; Ammar C; Ederhy S; Peyrol M; Debourdeau P; Serin D; Le Dolley Y; Michel N; Orabona M; Barraud J; Laine M; Bonello L; Paganelli F; Barlési F; Thuny F
Int J Cardiol; 2016 Dec; 224():366-375. PubMed ID: 27673693
[TBL] [Abstract][Full Text] [Related]
11. [The Cardio-Oncology Guideline - A Comprehensive Approach to Managing Cardiovascular Risks in Cancer Patients].
Romann SW; Frey N; Lehmann L
Dtsch Med Wochenschr; 2024 Jun; 149(12):719-723. PubMed ID: 38781996
[TBL] [Abstract][Full Text] [Related]
12. Cardio-oncology: the new frontier of clinical and preventive cardiology.
Paris S; Tarantini L; Navazio A; Faggiano P
Monaldi Arch Chest Dis; 2020 Jun; 90(2):. PubMed ID: 32571000
[TBL] [Abstract][Full Text] [Related]
13. Heartbreaker: Detection and prevention of cardiotoxicity in hematological malignancies.
Vakilpour A; Lefebvre B; Lai C; Scherrer-Crosbie M
Blood Rev; 2024 Mar; 64():101166. PubMed ID: 38182490
[TBL] [Abstract][Full Text] [Related]
14. Interactions between cardiology and oncology drugs in precision cardio-oncology.
Kamaraju S; Mohan M; Zaharova S; Wallace B; McGraw J; Lokken J; Tierney J; Weil E; Fatunde O; Brown SA
Clin Sci (Lond); 2021 Jun; 135(11):1333-1351. PubMed ID: 34076246
[TBL] [Abstract][Full Text] [Related]
15. Cardio-Oncology in Childhood: State of the Art.
Bennati E; Girolami F; Spaziani G; Calabri GB; Favre C; Parrini I; Lucà F; Tamburini A; Favilli S
Curr Oncol Rep; 2022 Dec; 24(12):1765-1777. PubMed ID: 36181610
[TBL] [Abstract][Full Text] [Related]
16. Organization and implementation of a cardio-oncology program.
Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
[TBL] [Abstract][Full Text] [Related]
17. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units].
Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G
Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680
[TBL] [Abstract][Full Text] [Related]
18. [Cardiotoxicity relatively common in cancer treatment].
Bühlmann Lerjen E; Hübbert L; Papakonstantinou A; Hedayati E; Linde C; Månsson Broberg A
Lakartidningen; 2016 Jun; 113():. PubMed ID: 27299327
[TBL] [Abstract][Full Text] [Related]
19. Rationale and proposal for cardio-oncology services in Italy.
Galderisi M; Santoro C; Bossone E; Mancusi C
J Cardiovasc Med (Hagerstown); 2022 Apr; 23(4):207-215. PubMed ID: 32858628
[TBL] [Abstract][Full Text] [Related]
20. The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology.
Fatunde OA; Brown SA
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]